Policies mandating the sharing of individual-level data from biomedical and public health research are becoming widespread and commanding increasing support from large funding bodies, regulatory agencies, and the pharmaceutical industry ([@bibr45-1556264615594767]; [@bibr49-1556264615594767]; [@bibr50-1556264615594767]; [@bibr62-1556264615594767]; [@bibr77-1556264615594767]; [@bibr78-1556264615594767]; [@bibr81-1556264615594767]; [@bibr82-1556264615594767]). Discussions of data release in the literature highlight the importance of taking seriously both ethical arguments for sharing individual-level data from health research and the need to develop appropriate governance and protections ([@bibr2-1556264615594767]; [@bibr19-1556264615594767]; [@bibr27-1556264615594767]; [@bibr83-1556264615594767]; [@bibr86-1556264615594767]).

The increasing amount of clinical and public health research being conducted in low- and middle-income settings has the potential to generate datasets of significant value to researchers seeking to address disease burdens in such settings ([@bibr44-1556264615594767]). Consequently, there is a pressing need to determine how best to develop effective, ethical, and sustainable approaches to data sharing in such contexts. Experiences of data release for genomic research suggest that challenges raised by individual-level data sharing in low- and middle-income settings will be different in important and morally significant ways from those arising in high-income settings ([@bibr52-1556264615594767]). In particular, although timely data sharing may be particularly important in low- and middle-income settings to inform effective and urgently needed public health interventions, it is important that data sharing is conducted in a way that does not disadvantage or harm researchers, research institutions, communities, and participants in such settings. Potential benefits and harms of data sharing are discussed in more detail below and summarized in [Table 1](#table1-1556264615594767){ref-type="table"}.

###### 

Summary of Potential Benefits of and Concerns About Data Sharing.
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  Reasons to share individual-level data                                                                                                                                                                                                                                                                                                                                                                                                          Concerns about sharing individual-level data
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  To improve scienceEnable verification, replication, and expansion of research resultsAddress biases, deficiencies, and dishonesty in researchEnable novel analyses and increase study powerImprove meta-analysesMaximize data use, particularly for datasets that cannot be replicatedInform research design and research fundingImprove teaching resourcesIncrease primary data producers' academic profiles and collaboration opportunities   May hamper scienceReputational harms of critical secondary analysesConsequences of flawed/poor quality secondary analysesReduction of incentives for primary researchIncreased incentives to conduct short-term research rather than long-term researchOpportunity costs of curating and sharing data
  To improve healthInform health care planning and allocationInform regulatory reviewImprove evidence base for clinical decision makingImprove use of health care resourcesImprove patient care                                                                                                                                                                                                                                                   May hamper healthEffects of flawed secondary analyses on scientific evidence baseBurden of evaluating validity of secondary analysesEffects of second-guessing regulatory procedures, policies, and processes
  Explicit moral claimsImportance of maximizing the value and utility of dataPromotion of scientific valuesPromotion of best practices in research conduct, analysis, and reportingDemonstration of respect for research participantsPromotion of the public good                                                                                                                                                                                 Explicit ethical issuesProtection of participants' privacy and confidentialityValidity of consent, including broad consentPotential harms of secondary research for research participants including discrimination and stigmaResearchers' ability to fulfill commitments made to research participants during data collectionEffects of moral distance and limited awareness of the context in which data were collectedPotential impacts on public trust and confidence of conflicting analysesBalancing the interests of differing stakeholders in data sharingMaking best use of limited research resources
                                                                                                                                                                                                                                                                                                                                                                                                                                                  Barriers to sharingCosts of developing and maintaining appropriate expertise and infrastructureCuration costsOwnership, intellectual property rights, and commercial confidentialityLack of policies and processes

Potential Advantages of Data Sharing {#section1-1556264615594767}
====================================

Sharing individual-level data from clinical and public health research can be valuable in multiple ways. Sharing data allows for independent scrutiny of research results to ensure they are reliable and reproducible, and increases the accountability of researchers ([@bibr20-1556264615594767]; [@bibr22-1556264615594767]; [@bibr41-1556264615594767]; [@bibr44-1556264615594767]; [@bibr46-1556264615594767]; [@bibr70-1556264615594767]). This may be particularly important where there are differing approaches to analyses ([@bibr72-1556264615594767]) or where there are concerns that reports of research have been selective, biased, or dishonest ([@bibr17-1556264615594767]; [@bibr25-1556264615594767]; [@bibr60-1556264615594767]; [@bibr63-1556264615594767]; [@bibr64-1556264615594767]). Sharing data also enables identification of gaps in research and can inform both future research priorities and research design ([@bibr19-1556264615594767]; [@bibr24-1556264615594767]; [@bibr67-1556264615594767]; [@bibr75-1556264615594767]). Some datasets of particular value may not be able to be re-collected due to changes in available treatment and disease incidence, and may be useful as reference datasets, particularly in different contexts, such as low- and middle-income settings ([@bibr19-1556264615594767]; [@bibr67-1556264615594767]).

Many commentators have discussed the value of conducting novel analyses with shared datasets, including testing innovative statistical methods and alternative analytical approaches ([@bibr10-1556264615594767]; [@bibr13-1556264615594767]; [@bibr35-1556264615594767]; [@bibr54-1556264615594767]; [@bibr77-1556264615594767]; [@bibr80-1556264615594767]; [@bibr84-1556264615594767]). Meta-analyses combining individual-level datasets may provide more reliable results than those based on summary data ([@bibr8-1556264615594767]; [@bibr54-1556264615594767]). Meta-analyses may also provide different results from the primary studies and permit examination of topics such as the heterogeneity of treatment effects, subgroup effects, temporal and geographical effects, and identification of rare safety events ([@bibr1-1556264615594767]; [@bibr8-1556264615594767]; [@bibr11-1556264615594767]; [@bibr44-1556264615594767]; [@bibr46-1556264615594767]).

Additional arguments in favor of sharing data are that it can be an efficient and cost-effective means of maximizing the utility of a dataset for research purposes and for teaching and methodology development ([@bibr25-1556264615594767]; [@bibr44-1556264615594767]; [@bibr71-1556264615594767]; [@bibr81-1556264615594767]). Increasing use of collected data can also reduce unnecessary duplication of research, which in turn limits potential harms to and burdens on research participants ([@bibr19-1556264615594767]; [@bibr59-1556264615594767]; [@bibr75-1556264615594767]).

These claims suggest that data sharing can make a very important contribution to public health, by improving the evidence base used to make regulatory, funding, and clinical decisions, and to make the best use of available resources ([@bibr35-1556264615594767]; [@bibr36-1556264615594767]; [@bibr60-1556264615594767]; [@bibr63-1556264615594767]; [@bibr66-1556264615594767]). As a routine best practice in research, it may contribute to improving public faith in research and drug regulation, particularly by promoting accountability and transparency in processes where there are potential conflicts of interest ([@bibr28-1556264615594767]; [@bibr29-1556264615594767]; [@bibr59-1556264615594767]; [@bibr86-1556264615594767]).

In addition to the potential of advancing scientific development and health, commentators have discussed ethical imperatives for promoting data sharing. Principles of fairness and reciprocity require data be shared to benefit communities that fund research indirectly and that provide the data on which research relies ([@bibr42-1556264615594767]; [@bibr54-1556264615594767]; [@bibr75-1556264615594767]; [@bibr76-1556264615594767]; [@bibr81-1556264615594767]). In addition, respect for research participants requires that their contributions to research be maximized by making the best use of their data. In particular, expectations that the results of research will be disseminated to advance science must be honored ([@bibr25-1556264615594767]; [@bibr46-1556264615594767]; [@bibr54-1556264615594767]; [@bibr81-1556264615594767]).

Potential Disadvantages of Data Sharing {#section2-1556264615594767}
=======================================

Numerous concerns and issues about sharing individual-level health research data have been discussed in the literature in addition to potential benefits. A core concern is to ensure that the privacy of participants is protected during secondary uses of data ([@bibr7-1556264615594767]; [@bibr14-1556264615594767]; [@bibr19-1556264615594767]; [@bibr50-1556264615594767]; [@bibr69-1556264615594767]; [@bibr81-1556264615594767]; [@bibr86-1556264615594767]). Processes for de-identifying data must be not only robust but also proportionate if the utility of the data is to be preserved ([@bibr2-1556264615594767]; [@bibr15-1556264615594767]; [@bibr19-1556264615594767]). Concerns have been raised about the ability of primary researchers to guarantee that re-identification will not take place ([@bibr46-1556264615594767]), particularly when reverse engineering and/or the combination of datasets may increase chances of identifying specific participants ([@bibr20-1556264615594767]; [@bibr21-1556264615594767]; [@bibr50-1556264615594767]; [@bibr58-1556264615594767]; [@bibr85-1556264615594767]).

Although curating and sharing data may make the most efficient and effective use of datasets, preparing data for research and implementing appropriate policies and processes require significant effort, expertise, and resources ([@bibr1-1556264615594767]; [@bibr46-1556264615594767]; [@bibr60-1556264615594767]; [@bibr71-1556264615594767]; [@bibr81-1556264615594767]). Lack of resources needed to share data has been identified as an impediment to data release in empirical research in higher income settings ([@bibr46-1556264615594767]; [@bibr60-1556264615594767]; [@bibr61-1556264615594767]; [@bibr69-1556264615594767]; [@bibr71-1556264615594767]) and as a serious obstacle in low- and middle-income settings ([@bibr44-1556264615594767]; [@bibr54-1556264615594767]; [@bibr59-1556264615594767]; [@bibr84-1556264615594767]).

Concerns have been raised that if sufficient safeguards are not in place, inappropriately prepared or shared data may hamper, rather than promote, public health ([@bibr50-1556264615594767]; [@bibr53-1556264615594767]; [@bibr57-1556264615594767]; [@bibr74-1556264615594767]). Data may be misinterpreted, or the subject of biased, inappropriate, or poorly designed studies ([@bibr27-1556264615594767]; [@bibr39-1556264615594767]; [@bibr55-1556264615594767]; [@bibr60-1556264615594767]; [@bibr74-1556264615594767]; [@bibr85-1556264615594767]). The results of such studies may mislead health care providers and regulators, lead to false hopes or unfounded concerns about treatments, reduce public confidence in research, and result in litigation ([@bibr1-1556264615594767]; [@bibr7-1556264615594767]; [@bibr41-1556264615594767]; [@bibr46-1556264615594767]; [@bibr50-1556264615594767]; [@bibr65-1556264615594767]). In addition, incentives for novel biomedical research may be reduced, if secondary data users can "free-ride" on the efforts of those collecting the data ([@bibr7-1556264615594767]; [@bibr42-1556264615594767]; [@bibr58-1556264615594767]; [@bibr60-1556264615594767]; [@bibr65-1556264615594767]; [@bibr86-1556264615594767]).

Stakeholders' Interests in Data Sharing {#section3-1556264615594767}
=======================================

Sharing individual-level research data will affect the interests of stakeholders in different ways. Primary researchers have interests in conducting initial analyses of data they have collected, and in receiving appropriate acknowledgment for dataset production ([@bibr7-1556264615594767]; [@bibr43-1556264615594767]; [@bibr54-1556264615594767]; [@bibr76-1556264615594767]; [@bibr84-1556264615594767]). Research participants and the communities from which they are drawn have interests in understanding that data may be shared, the consequences of sharing, and ways in which potential harms of sharing can be minimized ([@bibr46-1556264615594767]; [@bibr53-1556264615594767]; [@bibr57-1556264615594767]). Research funders have interests in promoting the utility of datasets and may also have interests in commercial exploitation of research results ([@bibr1-1556264615594767]; [@bibr7-1556264615594767]; [@bibr19-1556264615594767]; [@bibr40-1556264615594767]; [@bibr46-1556264615594767]).

Data sharing policies and process must recognize and respond to the differing interests of stakeholders appropriately if they are to effectively promote the benefits of data sharing and minimize potential harms. Calls have been made for policies and processes for data sharing to be informed by, and developed in consultation with, relevant stakeholders ([@bibr44-1556264615594767]; [@bibr79-1556264615594767]; [@bibr84-1556264615594767]). This scoping review sought to map evidence about stakeholders' experiences of data sharing and their perspectives of best practices, particularly in low- and middle-income settings, with the aim of informing future policy development and research agendas ([@bibr51-1556264615594767]).

Method {#section4-1556264615594767}
======

Scoping reviews seek to identify literature relevant to the research objective and may include a variety of research formats and conceptual literature ([@bibr3-1556264615594767]; [@bibr4-1556264615594767]). This study sought to review published literature on stakeholders' experiences of sharing individual-level data from medical and public health research and views of ethical best practices reported in peer-reviewed journals. Inclusion criteria for the study encompassed a broad range of article types, including empirical studies, news articles, opinion pieces, features, editorials, reports of practice, and theoretical articles. The initial search strategies for capturing views in this range of article formats were developed through an iterative process and used a combination of text words and subject headings (see Online Supplementary Materials 1 at <http://jre.sagepub.com/supplemental>).

The following databases were searched for relevant studies: Embase (OvidSP)\[1974-present\], Global Health (OvidSP)\[1973-present\], Global Health Library--Regional Databases (Virtual Health Library) \[<http://www.globalhealthlibrary.net>\], MEDLINE(R) In-Process & Other Non-Indexed Citations and MEDLINE(R) (OvidSP) \[1946-present\], ABI Inform (Proquest) \[1971-current\], PAIS International (Proquest)\[1977-current\], Science Citation Index (Web of Science Core Collections, Thomson Reuters) \[1945-present\] and WHOLIS (Virtual Health Library) \[<http://www.globalhealthlibrary.net>\]. The original search was conducted on June 24, 2013, and searches were repeated on December 9, 2013, and June 27, 2014, to update findings. No language or publication date limits were applied. Research relevant to low- and middle-income countries was isolated and grouped using a geographic search filter; however, all references were screened. (The full search strategy for Medline is available in Online Supplementary Materials 2).

The total of 6,430 abstracts identified by the strategy were screened, 958 of which were flagged as being particularly relevant in low- and middle-income settings. A matrix of inclusion and exclusion criteria was developed to inform screening (see [Figure 1](#fig1-1556264615594767){ref-type="fig"}).

![PRISMA 2009 flow diagram of the scoping review.\
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All abstracts were reviewed by a single researcher, with sample of 20% of abstracts being co-reviewed by additional researchers using a trial outline of inclusion and exclusion criteria. After co-reviewing 20% of abstracts, the value of a dual review was assessed. Given the complexity of consistently determining from abstracts which articles contained discussions of relevant ethical, policy, and governance issues, and the large number of abstracts to be screened, multiple review of all the abstracts was considered inefficient. Instead, a single reviewer applied revised inclusion and exclusion criteria consistently, marking articles that were potentially relevant (228), and additional articles that required full text review to determine relevance (246). References from these two categories were imported into bibliographic software (Endnote X6), which was then used to track decisions during a detailed review ([@bibr38-1556264615594767]).

In scoping reviews, to ensure appropriate identification of the literature, it may be important to adopt an iterative approach to study selection ([@bibr3-1556264615594767]; [@bibr4-1556264615594767]). Following screening of full text articles, five empirical studies of stakeholders' perspectives of sharing individual-level data from clinical and public health research were identified, all of which reported views and practices of researchers and research institutions from high-income settings. During full-text screening, articles focusing on samples and individual-level data from biobanks and genomic research were not routinely excluded, particularly when they reported on perspectives from data subjects or from stakeholders in low- and middle-income settings. A subsequent review of ethical, policy, and governance issues raised in such papers demonstrated some important differences with issues raised by sharing data from clinical and public health research, and they were subsequently excluded from the review.

The full text of the final 69 shortlisted papers was imported into qualitative data analysis software (NVIVO 10; see [Table 2](#table2-1556264615594767){ref-type="table"}). Descriptive codes were developed to chart perceived advantages of data sharing, barriers and concerns about data sharing, and recommendations for best practices in governing data sharing.

###### 

Articles Included in the Scoping Review.
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  Type of Article                                              Articles of general relevance                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Articles of particular relevance in low-and middle-income settings
  ------------------------------------------------------------ --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Empirical research articles                                  [@bibr39-1556264615594767]; [@bibr60-1556264615594767]; [@bibr61-1556264615594767]; [@bibr69-1556264615594767]; [@bibr71-1556264615594767].                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
  Articles focusing on ethics, policy, and governance issues   [@bibr1-1556264615594767]; [@bibr2-1556264615594767]; [@bibr5-1556264615594767]; [@bibr7-1556264615594767]; [@bibr8-1556264615594767]; [@bibr10-1556264615594767]; [@bibr11-1556264615594767]; [@bibr13-1556264615594767], [@bibr14-1556264615594767], [@bibr15-1556264615594767]; [@bibr16-1556264615594767]; [@bibr17-1556264615594767]; [@bibr18-1556264615594767]; [@bibr19-1556264615594767]; [@bibr20-1556264615594767]; [@bibr21-1556264615594767]; [@bibr22-1556264615594767]; [@bibr23-1556264615594767]; [@bibr24-1556264615594767], [@bibr25-1556264615594767], [@bibr26-1556264615594767]; [@bibr27-1556264615594767]; [@bibr28-1556264615594767]; [@bibr29-1556264615594767]; [@bibr30-1556264615594767]; [@bibr32-1556264615594767], [@bibr33-1556264615594767]; [@bibr34-1556264615594767]; [@bibr35-1556264615594767]; [@bibr36-1556264615594767]; [@bibr40-1556264615594767]; [@bibr41-1556264615594767]; [@bibr42-1556264615594767]; [@bibr43-1556264615594767]; [@bibr46-1556264615594767]; [@bibr50-1556264615594767]; [@bibr53-1556264615594767]; [@bibr57-1556264615594767]; [@bibr58-1556264615594767]; [@bibr63-1556264615594767]; [@bibr64-1556264615594767]; [@bibr66-1556264615594767]; [@bibr65-1556264615594767]; [@bibr67-1556264615594767]; [@bibr70-1556264615594767]; [@bibr72-1556264615594767]; [@bibr73-1556264615594767]; [@bibr74-1556264615594767]; [@bibr75-1556264615594767]; [@bibr77-1556264615594767]; [@bibr79-1556264615594767]; [@bibr80-1556264615594767]; [@bibr81-1556264615594767]; [@bibr83-1556264615594767]; [@bibr85-1556264615594767]; [@bibr86-1556264615594767]   [@bibr44-1556264615594767]; [@bibr54-1556264615594767]; [@bibr55-1556264615594767]; [@bibr56-1556264615594767]; [@bibr59-1556264615594767]; [@bibr68-1556264615594767]; [@bibr76-1556264615594767]; [@bibr84-1556264615594767]

Results {#section5-1556264615594767}
=======

This section begins by reviewing empirical research into stakeholders' experiences of, and views about, best practices in sharing individual-level data from medical or public health research. It then outlines the views expressed in articles focusing on ethical, policy, and governance issues arising when sharing such data. It concludes by focusing on issues identified as particularly relevant to best practices when sharing data from low- and middle-income settings.

Empirical Research {#section6-1556264615594767}
------------------

There is very limited empirical research into stakeholders' experiences of sharing individual-level data from clinical or public health research, and their views about best practices when doing so. This review identified five empirical studies, all of which sampled researchers and reviewers from high-income settings. Details of the studies, including the primary findings reported in the original articles, are set out in [Table 3](#table3-1556264615594767){ref-type="table"}.

###### 

Empirical Research Into Stakeholders' Experiences and Perspectives.
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  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author, publication year     Study aim                                                                                                           Sample                                                                                                                                                 Methods                                                                                                                                                                                      Key findings
  ---------------------------- ------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------ -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  [@bibr39-1556264615594767]   Determine opinions of making original data available for alternative analysis.                                      21 (84%) of 25 invitees from pharmaceutical companies with an interest in rheumatology. Locations of respondents not discussed.                        Letter with brief rationale for sharing data and asking whether it would be useful for trial data related to a publication to be shared via a databank and if so, what issues might arise.   5 (24%) of respondents were in favor of sharing data via a databank and 16 (76%) were not.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       The four most common reasons for not sharing data were: it is inappropriate to conduct analyses not defined in the protocol, authors may be willing to share data for a specific purpose on request instead, other researchers may conduct inappropriate analyses due to a lack of awareness of aspects of the original study, and further analysis is *post hoc* and data dredging.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       12 (57%) participants thought difficulties might arise with sharing trial data due to commercial sensitivity extending beyond the point of publication.

  [@bibr61-1556264615594767]   Investigate the preparedness of researchers to share their data.                                                    21 (72%) of 29 inquiries sent to corresponding authors of research articles in the *British Medical Journal* Locations of respondents not discussed.   Emailed specific request to reanalyze the data used in a published study (15) or a general inquiry about willingness to share data from a published study(14).                               9 (60%) of authors receiving specific requests and 12 (86%) of authors receiving general requests responded. Of the 21 responding authors, one shared the dataset and one was prepared to share the dataset without further conditions, 10 were prepared to release the data in principle subject to further discussions/conditions, three would not release data (suggesting they conduct new analyses themselves or that sufficient data were available in the articles), and six were ultimately non-committal.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Authors wanted to know more about why the data were being requested and the proposed analyses. Some authors wanted more time to conduct their own analyses before sharing data, some required conditions to be met (such as payment or contracts to be completed) and others needed to consult with co-investigators prior to release.

  [@bibr69-1556264615594767]   To test effects of journal policies requiring data to be shared.                                                    10 requests for datasets from corresponding authors of research articles in PLoS Medicine or PLoS Clinical Trials\                                     An emailed request for a dataset to test a pre-specified hypothesis about prediction modeling.                                                                                               Two authors had changed institution and could not be contacted.\
                                                                                                                                                   Locations of respondents not discussed.                                                                                                                                                                                                                                                                                                             One author asked for further details and then shared the dataset.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Four authors declined to share the data. When reminded of the journal policy, one said that a formal request to the research group was required, two said it was too much work, the fourth said that he was not permitted to share the data and wouldn't have published in the journal if he'd known it was a requirement.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Three authors didn't respond to the first email, two of whom didn't respond to a second email and the third declined to share data because more analyses were proposed.

  [@bibr60-1556264615594767]   To investigate clinical trialists' opinions and experiences of sharing data with non-collaborating investigators.   317 (46%) of 683 corresponding authors of clinical trials published in 2010 or 2011 in one of the six highest impact general medical journals.\        38 item adaptive-response online survey.                                                                                                                                                     236 (74%) of respondents supported sharing de-identified data via repositories, and 229 (72%) thought investigators should be required to share data on request. 56 (18%) were required to deposit trial data in a repository by funders and 149 (47%) had received an individual request to share data.\
                                                                                                                                                   Respondents were from the United States or Canada---167 (53%)\                                                                                                                                                                                                                                                                                      Concerns about sharing data through repositories included: potentially misleading secondary analyses, ensuring appropriate data use, ensuring clarity of data elements, indirect costs associated with sharing, colleagues' abilities to publish original research, ability to publish own research, scientific or academic recognition, direct costs associated with sharing, protecting commercially sensitive information, obtaining consent, and maintaining confidentiality.\
                                                                                                                                                   Western Europe---113 (36%)\                                                                                                                                                                                                                                                                                                                         Reasons for denying individual requests for data related to: potentially misleading analyses, potential for misinterpretation of data, potential mistrust of requestor's intent, ability to publish own research, colleagues' ability to publish original research, indirect costs associated with sharing, potential prohibition by formal agreement, potential lack of recognition, protecting commercially sensitive information, direct costs associated with sharing, being unsure of employer or funder policy, protection of patient confidentiality, and potential lack of consent.\
                                                                                                                                                   Other---37 (12%).                                                                                                                                                                                                                                                                                                                                   Reasons for sharing data in response to individual requests included: promoting new research and open science, enhancing robustness of previous research, facilitating student or fellow opportunities, avoiding redundant data collection, increasing impact of own research, professional or personal relationship with the requestor, additional academic recognition, compliance with employer or funder policy, compliance with journal policy.

  [@bibr71-1556264615594767]   Evaluate support and identify major issues for establishing a central repository of individual participant data.    30 (42%) of 71 reviewers affiliated with the Cochrane Collaboration's individual participant data meta-analysis method group.\                         Synopsis and link to 16 question online survey.                                                                                                                                              25 (83%) of respondents thought a central repository would be valuable, 25 (83%) would be willing to deposit data in such a repository provided conditions met.\
                                                                                                                                                   Respondents were from the United Kingdom---22 (73%)\                                                                                                                                                                                                                                                                                                The five most commonly suggested conditions that needed to be met for deposition were: approval from primary data source, appropriate acknowledgment of primary data source, involvement of original investigators in the process, reassurance about who would access the data, and the presence of a scientific committee to review data access requests.\
                                                                                                                                                   Other European Countries---6 (20%)\                                                                                                                                                                                                                                                                                                                 The five most commonly expected governance arrangements were: restricted access requiring approval, data security, an oversight committee, appropriate recognition for data owners, and anonymised data.
                                                                                                                                                   Australia---1 (3%)\                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                   Canada---1 (3%).                                                                                                                                                                                                                                                                                                                                    
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Best Practices in Data Sharing {#section7-1556264615594767}
------------------------------

In the introduction to this article, stakeholders' views about potential benefits and harms of sharing individual-level data were outlined. When considering the implications of such potential benefits and harms for best practices in data sharing, the fundamental importance of protecting the privacy of research participants was universally acknowledged in the reviewed literature. Some authors went further and set out additional specific principles and considerations for best practices in ethical data sharing (see [Table 4](#table4-1556264615594767){ref-type="table"}).

###### 

Principles and Considerations to Inform Best Practices in Ethical Data Sharing.
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  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Principles and considerations                                                                                                                                                     Reference
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------
  Ensure sufficiently broad access to realize the benefits to scientific innovation and public health, which are the main justification for sharing.\                               [@bibr46-1556264615594767]
  Ensure data are used responsibly so that poor quality analyses do not harm public health.\                                                                                        
  Treatment of researchers qualified to access data must be evenhanded.                                                                                                             

  Data sharing processes must be accountable and transparent.                                                                                                                       [@bibr46-1556264615594767]; [@bibr58-1556264615594767]

  Equitable: The needs of researchers, secondary users, communities, and funders should be recognized and balanced.\                                                                [@bibr81-1556264615594767]
  Ethical: The privacy of individuals and dignity of communities should be protected and public health promoted by productive data use.\                                            
  Efficient: Proportionate approaches should build on existing practice to improve the quality and value of research.                                                               

  Ensure fair trade and not free trade in data.                                                                                                                                     [@bibr55-1556264615594767]; [@bibr81-1556264615594767]

  Ensure the rights and responsibilities of researchers generating data and data accessors are balanced.                                                                            [@bibr68-1556264615594767]

  Ensure the benefits of data sharing outweigh the harms, and consider whether restricting the flow of information to avoid rare adverse events is appropriate.                     [@bibr80-1556264615594767]

  Clearly specify public interests in data sharing and clearly specify any legitimate reasons to restrict access to research data (following market approval of an intervention).   [@bibr75-1556264615594767]

  Ensure that the analytic value of the data is preserved during the protection of privacy and confidentiality.                                                                     [@bibr70-1556264615594767]; [@bibr79-1556264615594767]

  Ensure data sharing processes are responsive to the context within which datasets were collected.                                                                                 [@bibr53-1556264615594767]

  Honor the altruism of research participants.                                                                                                                                      [@bibr86-1556264615594767]
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Governed Data Sharing {#section8-1556264615594767}
---------------------

To maximize the potential benefits of sharing de-identified data, some stakeholders recommended that de-identified datasets should typically be made available publicly, with minimal restrictions ([@bibr17-1556264615594767]; [@bibr19-1556264615594767]; [@bibr24-1556264615594767], [@bibr25-1556264615594767]; [@bibr28-1556264615594767]; [@bibr30-1556264615594767]; [@bibr64-1556264615594767]; [@bibr75-1556264615594767]; [@bibr79-1556264615594767]). In contrast, in the majority of reviewed papers, a governed approach to data release was considered valuable to minimize potential harms and maximize potential benefits. Some authors discussed specific advantages of adopting a governed approach to data sharing, as outlined in [Table 5](#table5-1556264615594767){ref-type="table"}.

###### 

Potential Benefits of a Governed Approach to Data Sharing.

![](10.1177_1556264615594767-table5)

  Potential benefits of curation                                                                                                                                                                                                                                               Reference
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Adequate safeguards can be established, bona fide access restrictions can be put in place.                                                                                                                                                                                   [@bibr55-1556264615594767]; [@bibr81-1556264615594767]
  Patient privacy is increased.                                                                                                                                                                                                                                                [@bibr17-1556264615594767]; [@bibr32-1556264615594767]; [@bibr36-1556264615594767]; [@bibr50-1556264615594767]
  Poor quality research, which may lead to erroneous conclusions, can be prevented following review and requirements to adhere to a rigorous analytical plan.                                                                                                                  [@bibr17-1556264615594767]; [@bibr19-1556264615594767]; [@bibr36-1556264615594767]; [@bibr44-1556264615594767]; [@bibr46-1556264615594767]; [@bibr50-1556264615594767]; [@bibr60-1556264615594767]
  Permits compliance with legislation and or regulation.                                                                                                                                                                                                                       [@bibr50-1556264615594767]
  Promotes adherence to commitments made during the consent process.                                                                                                                                                                                                           [@bibr36-1556264615594767]
  Enables researchers to fulfill responsibilities to ensure data are used ethically.                                                                                                                                                                                           [@bibr53-1556264615594767]
  Curation can be responsive to the types of data being shared. Differing approaches can be taken to aggregate and individual-level data, particularly valuable or sensitive datasets, and analyses that require detailed data that could potentially identify participants.   [@bibr21-1556264615594767]; [@bibr35-1556264615594767]; [@bibr58-1556264615594767]; [@bibr77-1556264615594767]; [@bibr79-1556264615594767]

To guide governed data sharing, stakeholders made a number of recommendations about appropriate policy development. The current lack of policies or inconsistent policies in some settings was considered both frustrating and inefficient, as well as providing loopholes for researchers who did not want to share data ([@bibr44-1556264615594767]). A number of papers recommended that harmonized policies with broad applicability be developed, following consultation with a broad range of stakeholders, including policy makers, researchers, patients, patient advocates, privacy experts, funders, research institutions, journal editors, ethicists, NGOs, and governments ([@bibr20-1556264615594767]; [@bibr35-1556264615594767]; [@bibr44-1556264615594767]; [@bibr46-1556264615594767]; [@bibr79-1556264615594767]; [@bibr84-1556264615594767]). These could be complemented by institutional policies where appropriate ([@bibr44-1556264615594767]; [@bibr57-1556264615594767]). Areas to be addressed in the policies are outlined in [Table 6](#table6-1556264615594767){ref-type="table"}. Some commentators questioned the effectiveness of guidelines and policies encouraging data sharing to date ([@bibr26-1556264615594767]; [@bibr46-1556264615594767]; [@bibr69-1556264615594767]; [@bibr80-1556264615594767]) and suggested legal requirements for data sharing be implemented ([@bibr26-1556264615594767]; [@bibr80-1556264615594767]).

###### 

Priority Areas for Policy Development.

![](10.1177_1556264615594767-table6)

  Areas for policy development                                                                                                                                                                                                                                                                                                              References
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------
  Appropriate analytic methods, data and meta-data standards, including means of preserving privacy                                                                                                                                                                                                                                         [@bibr41-1556264615594767]; [@bibr46-1556264615594767]; [@bibr54-1556264615594767]; [@bibr59-1556264615594767]; [@bibr80-1556264615594767]
  Determining where, how, when, and which data are archived and made available                                                                                                                                                                                                                                                              [@bibr44-1556264615594767]
  Determining for which trials data will be shared, which data and supporting documents will be available, the process for data sharing, how transparent the process will be, who will get access, what types of analyses are permitted, who will decide, what criteria will be used, and what ongoing role the trial sponsor might have.   [@bibr86-1556264615594767]
  Methods to permit evaluation of individual applications, including to ensure that the use does not harm participants and is in conformity with ethical approvals                                                                                                                                                                          [@bibr19-1556264615594767]; [@bibr77-1556264615594767]
  Transparent, explicit, and reasonable criteria for case by case decision making                                                                                                                                                                                                                                                           [@bibr46-1556264615594767]
  Requirements and rewards for the collection and curation of datasets for sharing                                                                                                                                                                                                                                                          [@bibr55-1556264615594767]; [@bibr81-1556264615594767]

Best Practices in Sharing Data From Low- and Middle-Income Settings {#section9-1556264615594767}
-------------------------------------------------------------------

In both the discussion of potential advantages and disadvantages of data sharing in the introductory section of this article, and the discussion of perspectives about best practices above, the views of authors discussing data sharing in low- and middle-income settings were similar to those expressed in the more substantial body of literature from higher income settings. In contrast to lower and middle-income settings, articles from higher income settings had more discussion about ways in which these issues had been addressed and data shared to date. When discussing how to provide resources for best practices in data sharing, and how to balance the interests of stakeholders in the data sharing process (particularly those generating datasets), views remained similar, but some different emphases also emerged.

The importance of balancing the interests of primary researchers and secondary data users has received considerable attention in the reviewed literature. Stakeholders from higher and lower income settings commented on the importance of ensuing that researchers received appropriate recognition for producing datasets in the subsequent publications by secondary analysts, in professional assessments, and in funding applications ([@bibr41-1556264615594767]; [@bibr44-1556264615594767]; [@bibr54-1556264615594767]; [@bibr55-1556264615594767]; [@bibr57-1556264615594767]; [@bibr59-1556264615594767]; [@bibr60-1556264615594767]; [@bibr65-1556264615594767]; [@bibr72-1556264615594767]; [@bibr71-1556264615594767]; [@bibr81-1556264615594767]; [@bibr84-1556264615594767]). Perspectives on authorship differed. Some commentators suggested that co-authorship or at least the chance to publish an associated response or commentary should be offered to the researchers who produced the dataset ([@bibr53-1556264615594767]; [@bibr69-1556264615594767]; [@bibr80-1556264615594767]). Others noted that the contribution of data creators may not be sufficient to warrant co-authorship of the secondary analysis ([@bibr1-1556264615594767]; [@bibr25-1556264615594767]).

Although some commentators considered the value of releasing data prior to publication ([@bibr77-1556264615594767]), others noted the value of exclusive fair use periods for researchers in higher and lower income settings ([@bibr21-1556264615594767]; [@bibr25-1556264615594767]; [@bibr44-1556264615594767]; [@bibr53-1556264615594767]; [@bibr54-1556264615594767]; [@bibr55-1556264615594767]; [@bibr60-1556264615594767]; [@bibr66-1556264615594767]; [@bibr69-1556264615594767]; [@bibr76-1556264615594767]; [@bibr80-1556264615594767]). Such periods ranged from 12 months from the end of data collection to unspecified lengths of time, which were, in some cases, linked to the publication of an article with primary findings.

Although limited resources may be a hindrance to data sharing in higher income settings, they were identified as a very significant barrier in lower income settings ([@bibr44-1556264615594767]; [@bibr54-1556264615594767]; [@bibr55-1556264615594767]; [@bibr56-1556264615594767]; [@bibr59-1556264615594767]; [@bibr68-1556264615594767]; [@bibr76-1556264615594767]; [@bibr81-1556264615594767]; [@bibr84-1556264615594767]). For high-quality individual-level data to be shared in databases with long-term sustainability, significant investment in human resources, technology, and infrastructure will be required. Training, mentoring, and career pathways need to be provided for a range of specialist support staff who will document and curate datasets and manage data release processes. Where data archives are hosted within low- and middle-income settings, expertise in managing biomedical information will be required in addition to the development of storage infrastructure.

Commentators have noted that it would be unfair to develop capacity to share data in low- and middle-income settings without also developing the capacity for data generators and secondary users from such settings to analyze that data ([@bibr55-1556264615594767]; [@bibr68-1556264615594767]; [@bibr81-1556264615594767]; [@bibr84-1556264615594767]). Collaboration between primary and secondary data users was discussed as a potential means of improving the quality of analyses in both higher and lower income settings ([@bibr21-1556264615594767]; [@bibr41-1556264615594767]; [@bibr53-1556264615594767]; [@bibr74-1556264615594767]). Stakeholders from lower income settings also focused on the value of such collaborations to build capacity among researchers generating datasets ([@bibr44-1556264615594767]; [@bibr55-1556264615594767]; [@bibr76-1556264615594767]; [@bibr84-1556264615594767]).

Discussion {#section10-1556264615594767}
==========

The reviewed literature demonstrated considerable support for sharing individual-level data from clinical and public health research. As discussed above, numerous recommendations have been made for best practices in governing such sharing, to ensure that potential benefits are promoted and potential harms are managed appropriately. Although significant consensus about some aspects of best practice is evident, such as the need to protect the privacy of research participants, there are differences of opinion about practical achievement of these, such as the measures needed to protect privacy and the extent to which privacy can be assured ([@bibr25-1556264615594767]; [@bibr46-1556264615594767]; [@bibr50-1556264615594767]). In other areas, there is less consensus about best practices. Opinions differ, for example, about the need for and length of protected time primary researchers should have with data before they are shared ([@bibr21-1556264615594767]; Toronto International Data Release Workshop Authors., 2009), and the nature of consent required, if any, for sharing de-identified data ([@bibr13-1556264615594767]; [@bibr53-1556264615594767]).

Commentators have suggested that gaps and inconsistencies in policies and practices for data sharing are frustrating and inefficient, and have recommended that consensus be sought on developing harmonized policies and processes for sharing individual-level data which are informed by stakeholders' views ([@bibr44-1556264615594767]; [@bibr84-1556264615594767]).

This review identified just five examples of empirical literature into stakeholders' experiences of and views about sharing individual-level data, all of which focused on the views of data producers and reviewers, primarily from higher income settings ([@bibr39-1556264615594767]; [@bibr60-1556264615594767]; [@bibr61-1556264615594767]; [@bibr69-1556264615594767]; [@bibr71-1556264615594767]). Four of the five studies have sample sizes of 30 or less, and three are five or more years old. Although the findings from these articles provide interesting insights into researchers' opinions and practices of sharing data, some of the perspectives are dated, and differences in the research questions and approaches mean that views of best practices have not been systematically elicited.

This review was unable to identify any empirical research into research participants' perspectives about sharing individual-level data from clinical and public health research that does not involve genetic, genomic, or biobank research. In addition, no research into stakeholders' experiences and perspectives of best practices in sharing clinical data in low- and middle-income settings was found. To develop best practices in data sharing that are appropriate in low- and middle-income settings, empirical research into the perspectives of stakeholders from such settings is needed. We suggest that research into the perspectives of research participants, community representatives, researchers, research ethics committees, and data managers be made a priority to inform current policy development initiatives. The following five articles in this special issue begin to address this gap in the literature and report on the results of empirical studies of stakeholders' perspectives in India, Kenya, Thailand, South Africa, and Vietnam ([@bibr9-1556264615594767]; [@bibr12-1556264615594767]; [@bibr31-1556264615594767]; [@bibr37-1556264615594767]; [@bibr47-1556264615594767]).

Eight of the conceptual articles in this scoping review focused on the perspectives of stakeholders from low- and middle-income settings ([@bibr44-1556264615594767]; [@bibr54-1556264615594767]; [@bibr55-1556264615594767], [@bibr56-1556264615594767]; [@bibr59-1556264615594767]; [@bibr68-1556264615594767]; [@bibr76-1556264615594767]; [@bibr84-1556264615594767]). These articles suggest that challenges raised by sharing individual-level data from low- and middle-income settings can differ in important and morally significant ways from those arising in high-income settings. An example is the critical importance of building capacity to generate, curate, share, and analyze high-quality datasets if data are to be shared effectively and fairly. Further theoretical analysis will be valuable to evaluate additional issues arising when sharing individual-level data in low- and middle-income settings, and to inform how best to address them ([@bibr6-1556264615594767]).

Limitations of the Review {#section11-1556264615594767}
-------------------------

Although double screening of all materials is desirable in systematic reviews, it was not possible in this case due to the volume of potential references identified and the complexity of determining the relevance of papers from the supplied abstracts. To minimize error and bias, 20% of abstracts were co-reviewed, and the strategy for a structured approach to analysis was discussed by the co-authors with the collaborating partners in this study. A second limitation of this review is that it was confined to literature in peer-reviewed publications. A valuable addition to the findings of this review would be a review of policies and processes currently in place for curating and sharing individual-level data from clinical and public health research.
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